HOOKIPA PHARMA INC's ticker is HOOK and the CUSIP is 43906K100. A total of 55 filers reported holding HOOKIPA PHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $68,372 | -1.3% | 110,993 | +40.9% | 0.00% | – |
Q2 2023 | $69,304 | +19.6% | 78,754 | 0.0% | 0.00% | – |
Q1 2023 | $57,963 | -10.7% | 78,754 | -1.7% | 0.00% | – |
Q4 2022 | $64,880 | -39.9% | 80,099 | -1.0% | 0.00% | – |
Q3 2022 | $108,000 | +13.7% | 80,908 | +38.2% | 0.00% | – |
Q2 2022 | $95,000 | -74.7% | 58,529 | -64.5% | 0.00% | – |
Q1 2022 | $376,000 | -6.7% | 164,799 | -4.7% | 0.00% | – |
Q4 2021 | $403,000 | -61.0% | 172,955 | -1.4% | 0.00% | – |
Q3 2021 | $1,033,000 | -48.3% | 175,479 | -19.6% | 0.00% | – |
Q2 2021 | $1,997,000 | -9.8% | 218,134 | +32.6% | 0.00% | – |
Q1 2021 | $2,213,000 | +33.3% | 164,542 | +9.9% | 0.00% | – |
Q4 2020 | $1,660,000 | +23.1% | 149,730 | +5.1% | 0.00% | – |
Q3 2020 | $1,349,000 | -17.6% | 142,459 | +1.0% | 0.00% | – |
Q2 2020 | $1,638,000 | +68.9% | 141,029 | +19.9% | 0.00% | – |
Q1 2020 | $970,000 | -8.1% | 117,635 | +36.2% | 0.00% | – |
Q4 2019 | $1,056,000 | +208.8% | 86,350 | +89.6% | 0.00% | – |
Q3 2019 | $342,000 | +375.0% | 45,552 | +328.0% | 0.00% | – |
Q2 2019 | $72,000 | – | 10,642 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 1,842,902 | $17,452,000 | 0.32% |
Samsara BioCapital, LLC | 116,602 | $1,104,000 | 0.31% |
Artal Group S.A. | 599,616 | $5,678,000 | 0.14% |
HHLR ADVISORS, LTD. | 943,254 | $8,933,000 | 0.07% |
DAFNA Capital Management LLC | 22,061 | $209,000 | 0.07% |
Baker Brothers Advisors | 700,481 | $6,634,000 | 0.03% |
ZACKS INVESTMENT MANAGEMENT | 72,064 | $682,000 | 0.01% |
HOWLAND CAPITAL MANAGEMENT LLC | 14,728 | $139,000 | 0.01% |
ETF MANAGERS GROUP, LLC | 14,374 | $139,000 | 0.00% |
Squarepoint Ops LLC | 12,699 | $120,000 | 0.00% |